Safety and Efficacy Study of AzaSiteĀ® in Subjects With Blepharitis (NCT00629941) | Clinical Trial Compass
CompletedPhase 4
Safety and Efficacy Study of AzaSiteĀ® in Subjects With Blepharitis
United States25 participantsStarted 2008-03
Plain-language summary
The purpose of this study is to evaluate the safety and efficacy of AzaSiteĀ® ophthalmic solution, 1% on signs \& symptoms of blepharitis and tear cytokine and eyelid bacterial load levels
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of moderate to severe chronic blepharitis
* If female of childbearing potential, are non-pregnant and non-lactating
Exclusion Criteria:
* Had ocular surface surgery (LASIK, refractive, etc.) within the past year
* Unwilling to discontinue use of contact lenses during the study
* Have glaucoma
* Unable or unwilling to withhold the use of lid scrubs during the study
* Have a serious systemic disease or uncontrolled medical condition that in the judgment of the investigator could confound study assessments or limit compliance
* Currently using any preserved topical ocular medications (with the exception of unpreserved tear substitutes) at the time of entry into the study or during study participation
What they're measuring
1
Change in clinical signs and symptoms associated with blepharitis